Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Akela Pharma Inc.
Austin, Texas, United Statesakelapharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Akela Pharma’s lead program was Fentanyl TAIFUN®, a fast acting fentanyl formulation delivered via the proprietary TAIFUN® dry powder inhaler, developed for breakthrough cancer pain. The product reached Phase III clinical trials as of late 2008. Another pipeline asset was a growth hormone releasing hormone analog that completed successful Phase IIa studies. However, by 2011, the company shifted focus to its profitable contract manufacturing business, PharmaForm, after termination of its Japanese partnership on Fentanyl Taifun and bankruptcy proceedings for its Finnish subsidiary.[4][5]
- Therapeutic areas
- OncologyPulmonologyEndocrinology
- Modalities
- Small moleculesInhaled therapeutics[3][5]
- Industry
- Contract Manufacturing Organization
02
Partnerships
Teikoku Seiyaku Co., Ltd. – former Japanese partner on Fentanyl Taifun program (terminated partnership in or before August 2011)[4]Janssen Pharmaceutica N.V. – licensed rights to Fentanyl TAIFUN® for Canada as of January 2008 [6]Corcept Therapeutics – client of PharmaForm division/manufacturing partner for Corlux® product [4]
Beyond the preview
Go deeper on Akela Pharma Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Akela Pharma Inc..